1306304

Aesica Pharmaceutical GmbH — FEI 3002943189

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
September 12, 2024
Fiscal Year
2024
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Monheim am Rhein (Germany)

Additional Details

Mutual Recognition Agreement (MRA)